← 返回

携带纳米剑的铁骑士在对抗口腔癌中诱导铁死亡

英文原题:Iron Knights with Nanosword Induced Ferroptosis in the Battle Against Oral Carcinoma.

查看英文原题

Iron Knights with Nanosword Induced Ferroptosis in the Battle Against Oral Carcinoma.

PubMed 2024/12/19(内容时间) Nano Lett Q1 · IF 9.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

口腔鳞状细胞癌(OSCC)具有细胞氧化还原失衡的特征,因此对铁死亡治疗尤为敏感。然而,传统铁死亡诱导剂存在一些缺点。本研究合成了以牛血清白蛋白(BSA)为配体的超小金锰纳米簇(AMNC),并将其包封于自然杀伤(NK)细胞来源的外泌体中,制成Exo-AMNCs复合物,用于靶向治疗OSCC并诱导铁死亡。不同于既往报道的合金金属纳米簇,AMNC不仅能与细胞内H₂O₂反应产生活性氧(ROS)并诱导铁死亡,BSA配体还可改善其生物相容性和水溶性。这些特性使AMNC适用于体内荧光成像。与NK细胞外泌体结合后,Exo-AMNCs复合物对OSCC表现出较强的靶向成像和治疗效果。进一步的机制研究表明,Exo-AMNCs可下调OSCC中过表达的脂肪量及肥胖相关蛋白(FTO),并调节铁死亡关键相关蛋白谷胱甘肽过氧化物酶4(GPX4)。

展开英文摘要原文

Oral squamous cell carcinoma (OSCC) is a tumor characterized by cellular redox imbalance, rendering it particularly sensitive to ferroptosis treatment.

However, traditional ferroptosis inducers have a few drawbacks. In this study, ultrasmall AuMn nanoclusters (AMNCs) with a bovine serum albumin (BSA) ligand were synthesized and encapsulated in natural killer (NK) cell-derived exosomes to form an Exo-AMNCs composite for targeted ferroptosis therapy of OSCC.

Unlike previously reported alloyed metal nanoclusters, not only do AMNCs react with intracellular H 2 O 2 to produce reactive oxygen species (ROS) and induce ferroptosis but also the BSA ligand improves biocompatibility and water solubility. These properties render AMNCs ideal for fluorescence imaging in vivo . When combined with NK cell exosomes, the Exo-AMNCs composite exhibited strong targeted imaging and therapeutic effects on OSCC.

Further investigation into the mechanistic details demonstrated that Exo-AMNCs downregulate the overexpression of fat mass and obesity-associated (FTO) in OSCC and regulate the key ferroptosis-related protein glutathione peroxidase 4 (GPX4).

论文信息

作者
Yang Z、Yang Z、Wang D、Li Y、Hao M、Tao B、Feng Q、Wu H
单位
Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun 130021, China.China
文献类型
非美国政府资助研究
期刊
Nano letters2025 Jan 8
原文标识
PubMed 39703040 · DOI 10.1021/acs.nanolett.4c05070